Answers are grounded in this paper and cite their sources.
Nanosensor detects cathepsin B activity in breast cancer cells, suggesting new diagnostic pathways.
Cathepsin B (CTSB) plays a key role in several processes that promote breast cancer progression, making its activity detection crucial for cancer analysis. In this study, we developed a surface-enhanced Raman scattering (SERS) and fluorescence seesaw nanosensor for probing CTSB activity in breast cancer cells. The nanosensor, termed Au-pep-TAMRA, was fabricated by conjugating carboxytetramethylrhodamine (TAMRA)-labeled peptide substrates (pep-TAMRA) to gold nanoparticles (Au NPs). The peptide substrates served dual functions: (1) as recognition units specifically cleavable by CTSB and (2) as linkers bridging the plasmonic Au NPs and TAMRA signal molecules. Upon CTSB-mediated proteolytic cleavage, the altered distance between Au NPs and TAMRA generated inversely correlated signal changes in the SERS (reduction) and fluorescence (recovery) channels. This dual-mode nanosensor exhibited an expanded detection range of 5–200 ng/mL (compared to the single-mode detection) while achieving a low limit of detection of 1.16 ng/mL. Cell experiment validated the nanosensor’s capacity to precisely determine CTSB activity in MDA-MB-231 cell lysates. The SERS-fluorescence switchable nanosensor demonstrates potential for advancing accurate diagnosis and personalized therapeutic strategies for breast cancer in clinical settings.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: